Profil
Timothy G.
Whitten is currently President & Chief Executive Officer at Insmed Ltd. since 2009.
Former positions include President, Chief Executive Officer & Director at Insmed, Inc. from 2010 to 2012; Chief Executive Officer & Director at Taiho Oncology, Inc. in 2026; President & Chief Executive Officer at Transave, Inc.; Vice President-Global Marketing at Bristol Myers Squibb Co.; and Senior VP-Commercial Operations & Development at Pharmacyclics LLC.
Education includes an MBA from the University of Virginia and an undergraduate degree from West Virginia University.
Aktive Positionen von Timothy G. Whitten
| Unternehmen | Position | Beginn |
|---|---|---|
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for the treatment of lung diseases | Vorstandsvorsitzender | 10.06.2009 |
Ehemalige bekannte Positionen von Timothy G. Whitten
| Unternehmen | Position | Ende |
|---|---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Vorstandsvorsitzender | 28.01.2026 |
| INSMED INCORPORATED | Präsident | 10.09.2012 |
| BRISTOL-MYERS SQUIBB COMPANY | Vertrieb & Marketing | - |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Präsident | - |
| PHARMACYCLICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Timothy G. Whitten
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West Virginia University
West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transave, Inc.
Transave, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled therapeutics to treat chronic respiratory infections | Health Technology |
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for the treatment of lung diseases | Health Technology |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Health Technology |
















